• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

The Phoenix Eagle Advisory Team

Intellectual Property - Vaughan Barlow

Intellectual Property - Vaughan Barlow

Vaughan Barlow, PhD, coordinates Phoenix Eagle’s global intellectual property team. Vaughan was appointed a partner Pizzeys Patent and Trademark Attorneys in Canberra in 2009. Vaughan has a Bachelor of Science with first class honours, a Bachelor of Laws and a PhD in immunology. He also holds a Master of Laws with honours majoring in intellectual property.

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.